GlassScriptPhysician profile
Krishnanath Gaitonde
NPI 1417060757
$33,653.25
in general payments reported to CMS, 2019-2025
40 companies · $356 in 2025
The $356 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $3,200 · 2021: $7,275 · 2022: $863 · 2023: $2,050 · 2024: $512 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,025 · Travel and Lodging: $894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,025.23 |
| Travel and Lodging | $893.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $12,000.00 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $10,532.91 | 2019-2025 | Bard Urinary Drainage Bag |
| Ethicon INC. | $6,820.00 | 2021 | |
| Angiodynamics, INC. | $2,147.50 | 2022-2025 | Nanoknife |
| Boston Scientific Corporation | $393.63 | 2022-2024 | Lithoclast, Lithovue |
| Teleflex LLC | $293.60 | 2021-2024 | Urolift |
| Janssen Biotech, INC. | $201.39 | 2021-2025 | Erleada, Akeega |
| Merck Sharp & Dohme LLC | $133.47 | 2019-2025 | Lynparza |
| Abbvie INC. | $96.84 | 2021-2025 | |
| Laborie Medical Technologies Corp. | $80.68 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| Myriad Genetic Laboratories, INC. | $78.70 | 2024-2025 | Prolaris |
| Edap Technomed INC | $78.60 | 2023-2024 | |
| Caris Mpi, INC. | $60.59 | 2025 | Mi Cancer Seek |
| Sumitomo Pharma America, INC. | $56.70 | 2023-2024 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $50.35 | 2021-2025 |
Show all 39 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$197.73 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishnanath Gaitonde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.